Abstract
Stereotactic body radiation therapy (SBRT) is a novel cancer treatment strategy where ultra-high doses per fraction are used, generally in the range of 8–20 Gy per fraction in a hypofractionated regimen of five or fewer fractions, to achieve a high biologically effective dose (BED). Such high doses per treatment were unimaginable in the past because of concerns about radiation-induced injury to organs at risk (OARs) if large volumes of OARs were irradiated to high doses. However, with recent technical advancements in highly conformal treatment planning, image-guided radiotherapy, and delivery technologies, it has become possible to safely deliver very large fractional doses of radiation to lesions in the lung, liver, spine, pancreas, and other disease sites. SBRT involves technically sophisticated treatment planning processes consisting of a chain of activities including: immobilization/simulation, motion management, imaging for treatment planning, segmentation, beam-setup and optimization, and plan verification. Clinicians are usually concerned of a possible compromise in treatment efficacy for any weak link in the planning chain process. A further cause for concern is the influence that errors or inaccuracies in the dose calculation may have on the treatment efficacy. Such errors arise from inherent limitations in the calculation algorithm used, which are more significant in some anatomical sites than others. In this chapter, treatment planning for linac-based delivery systems for lung, liver, spine, and pancreas is reviewed. In addition, the impact of the choice of calculation algorithm on the accuracy of dose distributions is discussed.
Author's Contribution M. Miften, S.K. Das, I. Chetty, D. Westerly made substantial contributions to the conception, design, drafting, and writing of this book chapter. This book chapter has been seen, read, and agreed upon in its content by all the designated authors.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Ahnesjo A (1989) Collapsed cone convolution of radiant energy for photon dose calculation in heterogeneous media. Med Phys 16(4):577–592
Ahnesjo A, Aspradakis MM (1999) Dose calculations for external photon beams in radiotherapy. Phys Med Biol 44(11):R99–R155
Alber M, Nusslin F (1999) An objective function for radiation treatment optimization based on local biological measures. Phys Med Biol 44:479
Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JA, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R (2008) Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer—a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study. Radiother Oncol 88(3):359–367. doi:10.1016/j.radonc.2008.07.019
Benedict SH, Yenice KM, Followill D, Galvin JM, Hinson W, Kavanagh B, Keall P, Lovelock M, Meeks S, Papiez L, Purdie T, Sadagopan R, Schell MC, Salter B, Schlesinger DJ, Shiu AS, Solberg T, Song DY, Stieber V, Timmerman R, Tome WA, Verellen D, Wang L, Yin FF (2010) Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 37(8):4078–4101
Berger M, Seltzer S (1973) ETRAN Monte Carlo code system for electron and photon transport through extended media. Radiation Shielding Information Center (RSIC) Report CCC-107. Oak Ridge National Laboratory, Oak Ridge
Bignardi M, Navarria P, Mancosu P, Cozzi L, Fogliata A, Tozzi A, Castiglioni S, Carnaghi C, Tronconi MC, Santoro A, Scorsetti M (2011) Clinical outcome of hypofractionated stereotactic radiotherapy for abdominal lymph node metastases. Int J Radiat Oncol Biol Phys 81(3):831–838. doi:10.1016/j.ijrobp.2010.05.032
Boike TP, Lotan Y, Cho LC, Brindle J, DeRose P, Xie XJ, Yan J, Foster R, Pistenmaa D, Perkins A, Cooley S, Timmerman R (2011) Phase I Dose-Escalation Study of Stereotactic Body Radiation Therapy for Low− and Intermediate−Risk Prostate Cancer. J Clin Oncol 29: 2020–2026
Bortfeld T (1999) Optimized planning using physical objectives and constraints. Semin in Radiat Oncol 9: 20–34
Bortfeld T, Webb S (2009) Single-arc IMRT? Phys Med Biol 54:N9
Bortfeld T, Jokivarsi K, Goitein M, Kung J, Jiang SB (2002) Effects of intra-fraction motion on IMRT dose delivery: statistical analysis and simulation. Phys Med Biol 47:2203
Bradley JD, El Naqa I, Drzymala RE, Trovo M, Jones G, Denning MD (2010) Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: the pattern of failure is distant. Int J Radiat Oncol Biol Phys 77(4):1146–1150. doi:10.1016/j.ijrobp.2009.06.017
Bral S, Gevaert T, Linthout N, Versmessen H, Collen C, Engels B, Verdries D, Everaert H, Christian N, De Ridder M, Storme G (2011) Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a phase II trial. Int J Radiat Oncol Biol Phys 80(5):1343–1349. doi:10.1016/j.ijrobp.2010.04.056
Bzdusek K, Friberger H, Eriksson K, HÃ¥rdemark B, Robinson D, Kaus M (2009) Development and evaluation of an efficient approach to volumetric arc therapy planning. Med Phys 36:2328
Cardinale RM, Wu Q, Benedict SH, Kavanagh BD, Bump E, Mohan R (1999) Determining the optimal block margin on the planning target volume for extracranial stereotactic radiotherapy. Int J Radiat Oncol Biol Phys 45(2):515–520
Chang BK, Timmerman RD (2007) Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol 30(6):637
Chang DT, Schellenberg D, Shen J, Kim J, Goodman KA, Fisher GA, Ford JM, Desser T, Quon A, Koong AC (2009) Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas. Cancer 115(3):665–672. doi:10.1002/cncr.24059
Chetty IJ, Curran B, Cygler JE, DeMarco JJ, Ezzell G, Faddegon BA, Kawrakow I, Keall PJ, Liu H, Ma CM, Rogers DW, Seuntjens J, Sheikh-Bagheri D, Siebers JV (2007) Report of the AAPM Task Group No. 105: issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys 34(12):4818–4853
Daly ME, Choi CYH, Gibbs IC, Adler JR, Chang SD, Lieberson RE, Soltys SG (2011) Tolerance of the spinal cord to stereotactic radiosurgery: insights from hemangioblastomas. Int J Radiat Oncol Biol Phys 80(1):213–220. doi:10.1016/j.ijrobp.2010.01.040
Das IJ, Ding GX, Ahnesjo A (2008) Small fields: nonequilibrium radiation dosimetry. Med Phys 35(1):206–215
Dawson LA, Eccles C, Bissonnette JP, Brock KK (2005) Accuracy of daily image guidance for hypofractionated liver radiotherapy with active breathing control. Int J Radiat Oncol Biol Phys 62(4):1247–1252
de Pooter JA, Romero AM, Wunderink W, Storchi PRM, Heijmen BJM (2008) Automated non-coplanar beam direction optimization improves IMRT in SBRT of liver metastasis. Radiother Oncol 88(3):376–381. doi:10.1016/j.radonc.2008.06.001
De Ruysscher D, Faivre-Finn C, Nestle U, Hurkmans CW, Le Pechoux C, Price A, Senan S (2010) European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose, high-precision radiotherapy for lung cancer. J Clin Oncol 28(36):5301–5310. doi:10.1200/jco.2010.30.3271
Dhakal S, Corbin KS, Milano MT, Philip A, Sahasrabudhe D, Jones C, Constine LS (2012) Stereotactic body radiotherapy for pulmonary metastases from soft-tissue sarcomas: excellent local lesion control and improved patient survival. Int J Radiat Oncol Biol Phys 82(2):940–945. doi:10.1016/j.ijrobp.2010.11.052
Ding GX, Duggan DM, Lu B, Hallahan DE, Cmelak A, Malcolm A, Newton J, Deeley M, Coffey CW (2007) Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy. Med Phys 34(7):2985–2994
Diot Q, Kavanagh B, Timmerman R, Miften M (2012) Biological-based optimization and volumetric modulated arc therapy delivery for stereotactic body radiation therapy. Med Phys 39(1):237
D’Souza WD, Naqvi SA, Yu CX (2005) Real-time intra-fraction-motion tracking using the treatment couch: a feasibility study. Phys Med Biol 50:4021
Dunlap NE, Cai J, Biedermann GB, Yang W, Benedict SH, Sheng K, Schefter TE, Kavanagh BD, Larner JM (2009) Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(3):796–801
Eccles CL, Dawson LA, Moseley JL, Brock KK (2011) Interfraction liver shape variability and impact on GTV position during liver stereotactic radiotherapy using abdominal compression. Int J Radiat Oncol Biol Phys 80(3):938–946. doi:10.1016/j.ijrobp.2010.08.003
Fakiris AJ, McGarry RC, Yiannoutsos CT, Papiez L, Williams M, Henderson MA, Timmerman R (2009) Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys 75(3):677–682. doi:10.1016/j.ijrobp.2008.11.042
Fippel M (1999) Fast Monte Carlo dose calculation for photon beams based on the VMC electron algorithm. Med Phys 26(8):1466–1475
Foote M, Letourneau D, Hyde D, Massicotte E, Rampersaud R, Fehlings M, Fisher C, Lewis S, La Macchia N, Yu E, Laperriere NJ, Sahgal A (2011) Technique for stereotactic body radiotherapy for spinal metastases. J Clin Neurosci 18(2):276–279. doi:10.1016/j.jocn.2010.04.033
Fraass B, Doppke K, Hunt M, Kutcher G, Starkschall G, Stern R, Van Dyke J (1998) American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: quality assurance for clinical radiotherapy treatment planning. Med Phys 25(10):1773–1829
Fritz P, Kraus HJ, Blaschke T, Muhlnickel W, Strauch K, Engel-Riedel W, Chemaissani A, Stoelben E (2008) Stereotactic, high single-dose irradiation of stage I non-small cell lung cancer (NSCLC) using four-dimensional CT scans for treatment planning. Lung Cancer 60(2):193–199. doi:10.1016/j.lungcan.2007.10.005
Gomez DR, Hunt MA, Jackson A, O’Meara WP, Bukanova EN, Zelefsky MJ, Yamada Y, Rosenzweig KE (2009) Low rate of thoracic toxicity inn palliative paraspinal single-fraction stereotactic body radiation therapy. Radiother Oncol 93(3):414–418. doi:10.1016/j.radonc.2009.10.017
Goodman KA, Wiegner EA, Maturen KE, Zhang ZG, Mo QX, Yang G, Gibbs IC, Fisher GA, Koong AC (2010) Dose-escalation study of single-fraction stereotactic body radiotherapy for liver malignancies. Int J Radiat Oncol Biol Phys 78(2):486–493. doi:10.1016/j.ijrobp.2009.08.020
Guckenberger M, Baier K, Polat B, Richter A, Krieger T, Wilbert J, Mueller G, Flentje M (2010) Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol 97(1):65–70. doi:10.1016/j.radonc.2010.04.027
Hall EJ, Giaccia AJ (2006) Radiobiology for the radiologist. Lippincott Williams & Wilkins, Philadelphia
Herfarth KK, Debus J, Lohr F, Bahner ML, Fritz P, Hoss A, Schlegel W, Wannenmacher MF (2000) Extracranial stereotactic radiation therapy: set-up accuracy of patients treated for liver metastases. Int J Radiat Oncol Biol Phys 46(2):329–335
Hong JC, Yu Y, Rao AK, Ditererich S, Maxim PG, Le QT, Diehn M, Sze DY, Kothary N, Loo BW (2011) High retention and safety of percutaneously implanted endovascular embolization coils as fiducial markers for image-guided stereotactic ablative radiotherapy of pulmonary tumors. Int J Radiat Oncol Biol Phys 81(1):85–90. doi:10.1016/j.ijrobp.2010.04.037
Hoppe BS, Laser B, Kowalski AV, Fontenla SC, Pena-Greenberg E, Yorke ED, Lovelock DM, Hunt MA, Rosenzweig KE (2008) Acute skin toxicity following stereotactic body radiation therapy FOr stage I non-small-cell lung cancer: who’s at risk? Int J Radiat Oncol Biol Phys 72(5):1283–1286. doi:10.1016/j.ijrobp.2008.08.036
Ikushima H, Balter P, Komaki R, Hunjun S, Bucci MK, Liao ZX, McAleer MF, Yu ZQH, Zhang YB, Chang JY, Dong L (2011) Daily alignment results of in-room computed tomography-guided stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 79(2):473–480. doi:10.1016/j.ijrobp.2009.11.009
Jiang SB, Pope C, Jarrah KMA, Kung JH, Bortfeld T, Chen GTY (2003) An experimental investigation on intra-fractional organ motion effects in lung IMRT treatments. Phys Med Biol 48:1773
Jin L, Wang L, Li J, Luo W, Feigenberg SJ, Ma CM (2007) Investigation of optimal beam margins for stereotactic radiotherapy of lung-cancer using Monte Carlo dose calculations. Phys Med Biol 52:3549
Kawrakow I (2001) VMC++, electron and photon Monte Carlo calculations optimized for radiation treatment planning. In: Kling A, Barao F, Nakagawa M, Tavora L, Vaz P (eds) Advanced Monte Carlo for radiation physics, particle transport simulation and applications: proceedings of the Monte Carlo 2000 meeting Lisbon. Springer, Berlin, pp 229–236
Keall PJ, Cattell H, Pokhrel D, Dieterich S, Wong KH, Murphy MJ, Vedam SS, Wijesooriya K, Mohan R (2006) Geometric accuracy of a real-time target tracking system with dynamic multileaf collimator tracking system. Int J Radiat Oncol Biol Phys 65(5):1579–1584
Kelly P, Balter PA, Rebueno N, Sharp HJ, Liao ZX, Komaki R, Chang JY (2010) Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys 78(5):1387–1393. doi:10.1016/j.ijrobp.2009.09.070
Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, Ford J, Poen J, Gibbs IC, Mehta VK, Kee S, Trueblood W, Yang G, Bastidas JA (2004) Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 58(4):1017–1021
Kopek N, Holt MI, Hansen AT, Hoyer M (2010) Stereotactic body radiotherapy for unresectable cholangiocarcinoma. Radiother Oncol 94(1):47–52. doi:10.1016/j.radonc.2009.11.004
Lax I, Blomgren H, Naslund I, Svanstrom R (1994) Stereotactic radiotherapy of malignancies in the abdomen: methodological aspects. Acta Oncol 33(6):677–683
Lee MT, Kim JJ, Dinniwell R, Brierley J, Lockwood G, Wong R, Cummings B, Ringash J, Tse RV, Knox JJ, Dawson LA (2009) Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 27(10):1585–1591. doi:10.1200/jco.2008.20.0600
Li WN, Purdie TG, Taremi M, Fung SR, Brade A, Cho BCJ, Hope A, Sun A, Jaffray DA, Bezjak A, Bissonnette JP (2011) Effect of immobilization and performance status on intrafraction motion for stereotactic lung radiotherapy: analysis of 133 patients. Int J Radiat Oncol Biol Phys 81(5):1568–1575. doi:10.1016/j.ijrobp.2010.09.035
Lim DH, Yi BY, Mirmiran A, Dhople A, Suntharalingam M, D’Souza WD (2010) Optimal beam arrangement for stereotactic body radiation therapy delivery in lung tumors. Acta Oncol 49(2):219–224. doi:10.3109/02841860903302897
Liu R, Wagner TH, Buatti JM, Modrick J, Dill J, Meeks SL (2004) Geometrically based optimization for extracranial radiosurgery. Phys Med Biol 49:987
Mackie TR, Scrimger JW, Battista JJ (1985) A convolution method of calculating dose for 15-MV X rays. Med Phys 12(2):188–196
Mahadevan A, Jain S, Goldstein M, Miksad R, Pleskow D, Sawhney M, Brennan D, Callery M, Vollmer C (2010) Stereotactic body radiotherapy and gemcitabine for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 78(3):735–742. doi:10.1016/j.ijrobp.2009.08.046
Mahadevan A, Floyd S, Wong E, Jeyapalan S, Groff M, Kasper E (2011) Stereotactic body radiotherapy reirradiation for recurrent epidural spinal metastases. Int J Radiat Oncol Biol Phys 81(5):1500–1505. doi:10.1016/j.ijrobp.2010.08.012
Matuszak MM, Yan D, Grills I, Martinez A (2010) Clinical applications of volumetric modulated arc therapy. Int J Radiat Oncol Biol Phys 77(2):608–616
McCammon R, Schefter TE, Gaspar LE, Zaemisch R, Gravdahl D, Kavanagh B (2009) Observation of a dose-control relationship for lung and liver tumors after stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 73(1):112–118. doi:10.1016/j.ijrobp.2008.03.062
McGrath SD, Matuszak MM, Yan D, Kestin LL, Martinez AA, Grills IS (2010) Volumetric modulated arc therapy for delivery of hypofractionated stereotactic lung radiotherapy: a dosimetric and treatment efficiency analysis. Radiother Oncol 95(2):153–157
McQuaid D, Webb S (2006) IMRT delivery to a moving target by dynamic MLC tracking: delivery for targets moving in two dimensions in the beam’s eye view. Phys Med Biol 51:4819
Miften M, Wiesmeyer M, Kapur A, Ma CM (2001) Comparison of RTP dose distributions in heterogeneous phantoms with the BEAM Monte Carlo simulation system. J Appl Clin Med Phys 2(1):21–31
Nelson WR, Hirayama H, Rogers DWO (1985) The EGS4 code system. Report SLAC-265. Stanford linear accelerator, Stanford CA
Nelson JW, Yoo DS, Sampson JH, Isaacs RE, Larrier NA, Marks LB, Yin FF, Wu QJ, Wang ZH, Kirkpatrick JP (2009) Stereotactic body radiotherapy for lesions of the spine and paraspinal regions. Int J Radiat Oncol Biol Phys 73(5):1369–1375. doi:10.1016/j.ijrobp.2008.06.1949
Nguyen QN, Shiu AS, Rhines LD, Wang H, Allen PK, Wang XS, Chang EL (2010) Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 76(4):1185–1192. doi:10.1016/j.ijrobp.2009.03.062
Niemierko A, Urie M, Goitein M (1992) Optimization of 3D radiation therapy with both physical and biological end points and constraints. Int J Radiat Oncol Biol Phys 23(1):99–108
Ong CL, Palma D, Verbakel W, Slotman BJ, Senan S (2010) Treatment of large stage I-II lung tumors using stereotactic body radiotherapy (SBRT): Planning considerations and early toxicity. Radiother Oncol 97(3):431–436. doi:10.1016/j.radonc.2010.10.003
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T (2011) Stereotactic body radiotherapy (SBRT) for operable stage I non small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys 81(5):1352–1358. doi:10.1016/j.ijrobp.2009.07.1751
Otto K (2008) Volumetric modulated arc therapy: IMRT in a single gantry arc. Med Phys 35:310
Palma D, Vollans E, James K, Nakano S, Moiseenko V, Shaffer R, McKenzie M, Morris J, Otto K (2008) Volumetric modulated arc therapy (VMAT) for delivery of prostate radiotherapy: Reduction in treatment time and monitor unit requirements compared to intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 72(1):S312–S312
Palta JR, Mackie TR (eds) (2003) Intensity Modulated radiation therapy: the state of the art. Medical Physics Publishing, Madison
Papanikolaou N, Battista J, Boyer A, Kappas C, Klein E, Mackie T, Sharpe M, Van Dyk J (2004) AAPM Report No. 85: tissue inhomogeneity corrections for megavoltage photon beams. AAPM report No. 85. Medical Physics Publishing, Madison, pp 1–135
Papiez L, Timmerman R, Desrosiers C, Randall M (2003) Extracranial stereotactic radioablation physical principles. Acta Oncol 42(8):882–894
Peng Y, Vedam S, Chang JY, Gao S, Sadagopan R, Bues M, Balter P (2011) Implementation of feedback-guided voluntary breath-hold gating for cone beam CT-based stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 80(3):909–917. doi:10.1016/j.ijrobp.2010.08.011
Potters L, Kavanagh B, Galvin JM, Hevezi JM, Janjan NA, Larson DA, Mehta MP, Ryu S, Steinberg M, Timmerman R, Welsh JS, Rosenthal SA (2010) American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 76(2):326–332. doi:10.1016/j.ijrobp.2009.09.042
Radiation Therapy Oncology Group (2005) RTOG 0236: a phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I/II non-small cell lung cancer. http://wwwrtogorg/ClinicalTrials/ProtocolTableaspx
Rao M, Yang W, Chen F, Sheng K, Ye J, Mehta V, Shepard D, Cao D (2010) Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT: plan quality, delivery efficiency and accuracy. Med Phys 37:1350
Reynaert N, van der Marck SC, Schaart DR, Van der Zee W, Van Vliet-Vroegindeweij C, Tomsej M, Jansen J, Heijmen B, Coghe M, De Wagter C (2007) Monte Carlo treatment planning for photon and electron beams. Radiat Phys Chem 76:643–686
Riet A, Mak ACA, Moerland MA, Elders LH, van der Zee W (1997) A conformation number to quantify the degree of conformality in brachytherapy and external beam irradiation: application to the prostate. Int J Radiat Oncol Biol Phys 37(3):731–736
Rogers DWO, Faddegon BA, Ding GX, Ma CM, We J, Mackie TR (1995) BEAM: a Monte Carlo code to simulate radiotherapy treatment units. Med Phys 22(5):503–524
Rusthoven KE, Kavanagh BD, Cardenes H, Stieber VW, Burri SH, Feigenberg SJ, Chidel MA, Pugh TJ, Franklin W, Kane M, Gaspar LE, Schefter TE (2009) Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 27(10):1572–1578. doi:10.1200/jco.2008.19.6329
Rwigema JCM, Parikh SD, Heron DE, Howell M, Zeh H, Moser AJ, Bahary N, Quinn A, Burton SA (2011) Stereotactic body radiotherapy in the treatment of advanced adenocarcinoma of the pancreas. Am J Clin Oncol-Cancer Clin Trials 34(1):63–69. doi:10.1097/COC.0b013e3181d270b4
Sahgal A, Ames C, Chou D, Ma LJ, Huang K, Xu W, Chin C, Weinberg V, Chuang C, Weinstein P, Larson DA (2009) Stereotactic body radiotherapy is effective salvage therapy for patients with prior radiation of spinal metastases. Int J Radiat Oncol Biol Phys 74(3):723–731. doi:10.1016/j.ijrobp.2008.09.020
Sahgal A, Ma L, Gibbs I, Gerszten PC, Ryu S, Soltys S, Weinberg V, Wong S, Chang E, Fowler J, Larson DA Spinal cord tolerance for stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 77(2):548–553
Schefter TE, Kavanagh BD, Timmerman RD, Cardenes HR, Baron A, Gaspar LE (2005) A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 62(5):1371–1378
Schellenberg D, Kim J, Ciristman-Skieller C, Chun CL, Columbo LA, Ford JM, Fisher GA, Kunz PL, Van Dam J, Quon A, Desser TS, Norton J, Hsu A, Maxim PG, Xing L, Goodman KA, Chang DT, Koong AC (2011) Single-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 81(1):181–188. doi:10.1016/j.ijrobp.2010.05.006
Seo YS, Kim MS, Yoo SY, Cho CK, Choi CW, Kim JH, Han CJ, Park SC, Lee BH, Kim YH, Lee DH (2010) Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma. J Surg Oncol 102(3):209–214. doi:10.1002/jso.21593
Shaw E, Kline R, Gillin M, Souhami L, Hirschfeld A, Dinapoli R, Martin L (1993) Radiation therapy oncology group: radiosurgery quality assurance guidelines. Int J Radiat Oncol Biol Phys 27(5):1231–1239
Solberg TD, Boedeker KL, Fogg R, Selch MT, DeSalles AAF (2001) Dynamic arc radiosurgery field shaping: a comparison with static field conformal and noncoplanar circular arcs. Int J Radiat Oncol Biol Phys 49(5):1481–1491
Solberg TD, Balter JM, Benedict SH, Fraass BA, Kavanagh B, Miyamoto C, Pawlicki T, Potters L, Yamada Y (2012) Quality and safety considerations in stereotactic radiosurgery and stereotactic body radiation therapy: executive summary. Pract Radiat Oncol 2:2–9
Song SY, Choi W, Shin SS, Lee SW, Do Ahn S, Kim JH, Je HU, Il Park C, Lee JS, Choi EK (2009) Fractionated stereotactic body radiation therapy for medically inoperable stage I lung cancer adjacent to central large bronchus. Lung Cancer 66(1):89–93. doi:10.1016/j.lungcan.2008.12.016
Sonke JJ, Rossi M, Wolthaus J, van Herk M, Damen E, Belderbos J (2009) Frameless stereotactic body radiotherapy for lung cancer using four-dimensional cone beam CT guidance. Int J Radiat Oncol Biol Phys 74(2):567–574. doi:10.1016/j.ijrobp.2008.08.004
Stephans KL, Djemil T, Tendulkar RD, Robinson CG, Reddy CA, Videtic GMM (2012) Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT). Int J Radiat Oncol Biol Phys 82(2):974–980. doi:10.1016/j.ijrobp.2010.12.002
Takeda A, Kunieda E, Ohashi T, Aoki Y, Koike N, Takeda T (2011) Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer. Radiother Oncol 101(2):255–259. doi:10.1016/j.radonc.2011.05.033
Tanyi JA, Summers PA, McCracken CL, Chen Y, Ku LC, Fuss M (2009) Implications of a high-definition multileaf collimator (HD-MLC) on treatment planning techniques for stereotactic body radiation therapy (SBRT): a planning study. Radiat Oncol 4:22
Taremi M, Hope A, Dahele M, Pearson S, Fung S, Purdie T, Brade A, Cho J, Sun A, Bissonnette JP, Bezjak A (2012) Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients. Int J Radiat Oncol Biol Phys 82(2):967–973. doi:10.1016/j.ijrobp.2010.12.039
Teh BS, Ishiyama H, Mathews T, Xu B, Butler EB, Mayr NA, Lo SS, Lu JJ, Blanco AI, Paulino AC, Timmerman RD (2010) Stereotactic body radiation therapy (SBRT) for genitourinary malignancies. Discov Med 10(52):255–262
Timmerman RD (2006) Development of a phase I/II clinical trial using sterotactic body radiation therapy (SBRT) for the treatment of localized prostate carcinoma. DTIC Document
Timmerman RD (2008) An overview of hypofractionation and introduction to this issue of seminars in radiation oncology. Semin Radiat Oncol 18:215–222
Timmerman R, Papiez L, McGarry R, Likes L, DesRosiers C, Frost S, Williams M (2003) Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer. Chest 124(5):1946–1955
Timmerman RD, Forster KM, Chinsoo Cho L (2005) Extracranial stereotactic radiation delivery. Semin in Radiat Oncol 15:202–207
Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L (2007) Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 25(8):947–952
Tipton KN, Sullivan N, Bruening W, Inamdar R, Launders J, Uhl S, Schoelles KM (2011) Stereotactic body radiation therapy. Compare Effectiveness Technical Report Briefs, No. 6, Agency for Health Care Research and Quality, Rockville.
van der Pool AEM, Romero AM, Wunderink W, Heijmen BJ, Levendag PC, Verhoef C, Ijzermans JNM (2010) Stereotactic body radiation therapy for colorectal liver metastases. Br J Surg 97(3):377–382. doi:10.1002/bjs.6895
Verbakel W, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ (2009) Rapid delivery of stereotactic radiotherapy for peripheral lung tumors using volumetric intensity-modulated arcs. Radiother Oncol 93(1):122–124. doi:10.1016/j.radonc.2009.05.020
Videtic GMM, Stephans K, Reddy C, Gajdos S, Kolar M, Clouser E, Djemil T (2010) Intensity-modulated radiotherapy based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. Int J Radiat Oncol Biol Phys 77(2):344–349. doi:10.1016/j.ijrobp.2009.05.004
Wang XH, Mohan R, Jackson A, Leibel SA, Fuks Z, Ling CC (1995) Optimization of intensity-modulated 3D conformal treatment plans based on biological indices. Radiother Oncol 37(2):140–152
Wu QJ, Yoo S, Kirkpatrick JP, Thongphiew D, Yin FF (2009) Volumetric arc intensity-modulated therapy for spine body radiotherapy: comparison with static intensity-modulated treatment. Int J Radiat Oncol Biol Phys 75(5):1596–1604. doi:10.1016/j.ijrobp.2009.05.005
Wulf J, Hädinger U, Oppitz U, Olshausen B, Flentje M (2000) Stereotactic radiotherapy of extracranial targets: CT-simulation and accuracy of treatment in the stereotactic body frame. Radiother Oncol 57(2):225–236
Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J, Zatcky J, Zelefsky MJ, Fuks Z (2008) High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 71(2):484–490
Yenice KM, Lovelock DM, Hunt MA, Lutz WR, Fournier-Bidoz N, Hua CH, Yamada J, Bilsky M, Lee H, Pfaff K (2003) CT image-guided intensity-modulated therapy for paraspinal tumors using stereotactic immobilization. Int J Radiat Oncol Biol Phys 55(3):583–593
Yin FF, Ryu S, Ajlouni M, Zhu J, Yan H, Guan H, Faber K, Rock J, Abdalhak M, Rogers L, Rosenblum M, Kim JH (2002) A technique of intensity-modulated radiosurgery (IMRS) for spinal tumors. Med Phys 29(12):2815–2822
Yu CX (1995) Intensity-modulated arc therapy with dynamic multileaf collimation: an alternative to tomotherapy. Phys Med Biol 40:1435
Yu CX, Jaffray DA, Wong JW (1998) The effects of intra-fraction organ motion on the delivery of dynamic intensity modulation. Phys Med Biol 43(1):91–104
Zimmerman J, Korreman S, Persson G, Cattell H, Svatos M, Sawant A, Venkat R, Carlson D, Keall P (2009) DMLC motion tracking of moving targets for intensity modulated arc therapy treatment-a feasibility study. Acta Oncol 48(2):245–250
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Miften, M., Das, S.K., Chetty, I.J., Westerly, D. (2012). Treatment Planning for Stereotactic Body Radiation Therapy. In: Lo, S., Teh, B., Lu, J., Schefter, T. (eds) Stereotactic Body Radiation Therapy. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2012_615
Download citation
DOI: https://doi.org/10.1007/174_2012_615
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-25604-2
Online ISBN: 978-3-642-25605-9
eBook Packages: MedicineMedicine (R0)